GlassScriptPhysician profile
Adam L Aronson
NPI 1487758603
$1,489.34
in general payments reported to CMS, 2019-2025
21 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $86.90 · 2021: $34.36 · 2022: $283 · 2023: $337 · 2024: $216 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $723.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $359.80 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Pfizer INC. | $188.77 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $140.81 | 2019-2024 | Vpriv |
| Kaleo, INC. | $132.19 | 2019-2024 | Auvi-Q |
| Sobi, INC | $90.10 | 2019-2023 | |
| Genzyme Corporation | $78.33 | 2023-2025 | |
| Glaxosmithkline, LLC. | $63.35 | 2019-2022 | |
| Cranial Technologies, INC | $58.13 | 2019-2020 | |
| Shire North American Group INC | $49.53 | 2019 | |
| Phadia US INC. | $43.36 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $38.89 | 2019-2024 | Flumist Quadrivalent |
| Sanofi Pasteur INC. | $37.01 | 2024 | |
| Supernus Pharmaceuticals, INC. | $35.79 | 2022 | |
| Cipher Pharmaceuticals US LLC | $33.92 | 2025 | Spinosad, Natroba |
| Alk-Abello, INC | $28.86 | 2025 | Neffy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $22.51 | 2024 | Azstarys |
| Ars Pharmaceuticals Operations, INC. | $21.66 | 2025 | Neffy |
| Vertical Pharmaceuticals, LLC | $18.33 | 2019 | |
| Alexion Pharmaceuticals, INC. | $17.55 | 2024 | Koselugo |
| Hologic Sales and Service, LLC | $15.63 | 2019 | |
| Verrica Pharmaceuticals INC. | $14.82 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Aronson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.